Reaction Details Report a problem with these data
Target
Nuclear receptor ROR-gamma [238-497]
Ligand
BDBM175896
Substrate
n/a
Meas. Tech.
M1H Assay
IC50
5445±n/a nM
Citation
 Finsinger, D; Wucherer-Plietker, M; Blume, B Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors US Patent  US9688684 Publication Date 6/27/2017 
Target
Name:
Nuclear receptor ROR-gamma [238-497]
Synonyms:
NR1F3 | RORC | RORG | RORG_HUMAN | RZRG | Retinoid-related orphan receptor gamma (RORgamma-LBD)
Type:
Protein
Mol. Mass.:
29835.99
Organism:
Homo sapiens (Human)
Description:
Human RORgamma ligand-binding domain.
Residue:
260
Sequence:
HPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAA
  
Inhibitor
Name:
BDBM175896
Synonyms:
US9688684, Compound 93: 8-(4-Fluoro-phenyl)-7-(3-methyl-benzyl)-5,6,7,8-tetrahydro-tetrazolo[1,5-a]pyrazine
Type:
Small organic molecule
Emp. Form.:
C18H18FN5
Mol. Mass.:
323.3674
SMILES:
Cc1cccc(CN2CCn3nnnc3C2c2ccc(F)cc2)c1
Structure:
Search PDB for entries with ligand similarity: